180 related articles for article (PubMed ID: 19199865)
21. Shp-2 tyrosine phosphatase: signaling one cell or many.
Feng GS
Exp Cell Res; 1999 Nov; 253(1):47-54. PubMed ID: 10579910
[TBL] [Abstract][Full Text] [Related]
22. Protein phosphatase-2A regulates protein tyrosine phosphatase activity in Lewis lung carcinoma tumor variants.
Jackson JL; Young MR
Clin Exp Metastasis; 2003; 20(4):357-64. PubMed ID: 12856723
[TBL] [Abstract][Full Text] [Related]
23. Leptin receptor activation of SH2 domain containing protein tyrosine phosphatase 2 modulates Ob receptor signal transduction.
Li C; Friedman JM
Proc Natl Acad Sci U S A; 1999 Aug; 96(17):9677-82. PubMed ID: 10449753
[TBL] [Abstract][Full Text] [Related]
24. The alphaVbeta3 integrin regulates insulin-like growth factor I (IGF-I) receptor phosphorylation by altering the rate of recruitment of the Src-homology 2-containing phosphotyrosine phosphatase-2 to the activated IGF-I receptor.
Maile LA; Clemmons DR
Endocrinology; 2002 Nov; 143(11):4259-64. PubMed ID: 12399420
[TBL] [Abstract][Full Text] [Related]
25. Protein tyrosine phosphatases in cancer: friends and foes!
Labbé DP; Hardy S; Tremblay ML
Prog Mol Biol Transl Sci; 2012; 106():253-306. PubMed ID: 22340721
[TBL] [Abstract][Full Text] [Related]
26. SH2-Containing protein tyrosine phosphatase-1 (SHP-1) association with Jak2 in UT-7/Epo cells.
Wu DW; Stark KC; Dunnington D; Dillon SB; Yi T; Jones C; Pelus LM
Blood Cells Mol Dis; 2000 Feb; 26(1):15-24. PubMed ID: 10772872
[TBL] [Abstract][Full Text] [Related]
27. Regulatory cascades of protein phosphatases: implications for cancer treatment.
Jailkhani N; Chaudhri VK; Rao KV
Anticancer Agents Med Chem; 2011 Jan; 11(1):64-77. PubMed ID: 21214508
[TBL] [Abstract][Full Text] [Related]
28. Oxidation sensitivity of the catalytic cysteine of the protein-tyrosine phosphatases SHP-1 and SHP-2.
Weibrecht I; Böhmer SA; Dagnell M; Kappert K; Ostman A; Böhmer FD
Free Radic Biol Med; 2007 Jul; 43(1):100-10. PubMed ID: 17561098
[TBL] [Abstract][Full Text] [Related]
29. Protein phosphatase 2A as a potential target for anticancer therapy.
Kalev P; Sablina AA
Anticancer Agents Med Chem; 2011 Jan; 11(1):38-46. PubMed ID: 21288198
[TBL] [Abstract][Full Text] [Related]
30. Targeting protein tyrosine phosphatases for anticancer drug discovery.
Scott LM; Lawrence HR; Sebti SM; Lawrence NJ; Wu J
Curr Pharm Des; 2010 Jun; 16(16):1843-62. PubMed ID: 20337577
[TBL] [Abstract][Full Text] [Related]
31. Negative regulation of FcepsilonRI signaling by FcgammaRII costimulation in human blood basophils.
Kepley CL; Cambier JC; Morel PA; Lujan D; Ortega E; Wilson BS; Oliver JM
J Allergy Clin Immunol; 2000 Aug; 106(2):337-48. PubMed ID: 10932079
[TBL] [Abstract][Full Text] [Related]
32. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein.
Higashi H; Tsutsumi R; Muto S; Sugiyama T; Azuma T; Asaka M; Hatakeyama M
Science; 2002 Jan; 295(5555):683-6. PubMed ID: 11743164
[TBL] [Abstract][Full Text] [Related]
33. CD150 association with either the SH2-containing inositol phosphatase or the SH2-containing protein tyrosine phosphatase is regulated by the adaptor protein SH2D1A.
Shlapatska LM; Mikhalap SV; Berdova AG; Zelensky OM; Yun TJ; Nichols KE; Clark EA; Sidorenko SP
J Immunol; 2001 May; 166(9):5480-7. PubMed ID: 11313386
[TBL] [Abstract][Full Text] [Related]
34. Chicken Ig-like receptor B2, a member of a multigene family, is mainly expressed on B lymphocytes, recruits both Src homology 2 domain containing protein tyrosine phosphatase (SHP)-1 and SHP-2, and inhibits proliferation.
Viertlboeck BC; Crooijmans RP; Groenen MA; Göbel TW
J Immunol; 2004 Dec; 173(12):7385-93. PubMed ID: 15585863
[TBL] [Abstract][Full Text] [Related]
35. SHP-2, SH2-containing protein tyrosine phosphatase-2.
Stein-Gerlach M; Wallasch C; Ullrich A
Int J Biochem Cell Biol; 1998 May; 30(5):559-66. PubMed ID: 9693956
[TBL] [Abstract][Full Text] [Related]
36. Investigational inhibitors of PTP4A3 phosphatase as antineoplastic agents.
Sharlow ER; Wipf P; McQueeney KE; Bakan A; Lazo JS
Expert Opin Investig Drugs; 2014 May; 23(5):661-73. PubMed ID: 24625356
[TBL] [Abstract][Full Text] [Related]
37. The N-terminal SH2 domain of the tyrosine phosphatase, SHP-2, is essential for Jak2-dependent signaling via the angiotensin II type AT1 receptor.
Godeny MD; Sayyah J; VonDerLinden D; Johns M; Ostrov DA; Caldwell-Busby J; Sayeski PP
Cell Signal; 2007 Mar; 19(3):600-9. PubMed ID: 17027227
[TBL] [Abstract][Full Text] [Related]
38. The association between integrin-associated protein and SHPS-1 regulates insulin-like growth factor-I receptor signaling in vascular smooth muscle cells.
Maile LA; Badley-Clarke J; Clemmons DR
Mol Biol Cell; 2003 Sep; 14(9):3519-28. PubMed ID: 12972543
[TBL] [Abstract][Full Text] [Related]
39. Potential involvement of FRS2 in insulin signaling.
Delahaye L; Rocchi S; Van Obberghen E
Endocrinology; 2000 Feb; 141(2):621-8. PubMed ID: 10650943
[TBL] [Abstract][Full Text] [Related]
40. The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors.
Wu CJ; O'Rourke DM; Feng GS; Johnson GR; Wang Q; Greene MI
Oncogene; 2001 Sep; 20(42):6018-25. PubMed ID: 11593409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
